Sankyo signs up Singapore pharma for natural product leads
Thursday, 21 April, 2005
Private Singapore natural products company MerLion Pharmaceuticals has sealed a three-year cooperative drug discovery and development collaboration with Japan's Sankyo.
The companies will collaborate on both the lead discovery and optimisation stages of the collaboration. Sankyo will provide selected high-throughput screens and additional assays to MerLion, which will provide access to its sample collection. Sankyo will undertake clinical development and commercialisation of the discoveries.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
